SHENZHEN SISENSING CO., LTDZ6.G11Established in 2015, Shenzhen Sibionics Technology Co., Ltd. is dedicated to the research and development, as well as the industrialization, of groundbreaking medical devices within the realm of chronic disease management. With a workforce exceeding 700 employees, the company has diligently pursued its mission of "Advancing medical technology, promoting public health." The nucleus of the team is helmed by distinguished scientists and engineers hailing from esteemed institutions such as Tsinghua University, Peking University, California Institute of Technology, Princeton University, University of Washington, and other renowned universities.
We obtained the CE Mark for the SIBIONICS GS1 CGM continuous glucose monitoring system on October 30, 2023. This GS1 CGM System offers users a 14-day calibration-free continuous glucose monitoring solution, allowing them to transmit glucose data to their monitoring devices or mobile apps and generate professional AGP reports. Additionally, the GS1 CGM supports data sharing with friends and family and seamlessly integrates with the advanced ProView remote access platform. This integration enables healthcare providers to monitor patients remotely and provide timely medical interventions when necessary, contributing to improved diabetes management.
